A federal appeals court has given a green light to a woman to proceed with a lawsuit in which she charges that a drugmaker breached its responsibility to supply patients with a needed medicine. The decision means that, for now, a debate will continue about holding drugmakers accountable for ongoing product shortages that have allegedly caused numerous individuals harm.
In this case, Jennifer Lacognata had been diagnosed with vitamin A deficiency and subsequently prescribed an injectable drug called Aquasol A that is made by Hospira. But shortly afterwards, she was unable to obtain the medicine because Hospira HSP) has had numerous manufacturing problems, which has prompted some Wall Street analysts to speculate the FDA may issue a consent decree (read this).
In filing her lawsuit, Lacognata, who is now blind in one eye due to vitamin A deficiency, highlighted a dilemma resulting from a large and persistent number of shortages over the past two years of numerous medications needed for treating different cancers and attention deficit disorder, among other ailments (see the list).
The crisis has led to patient deaths; gray market price gouging; an increased reliance on compounding pharmacies that have raised safety questions; Congressional probes; calls to fine drugmakers that fail to provide early notice of shortages, and accusations that the FDA has been overzealous in pursuing manufacturing gaffes, a charge the agency has denied. Amid this swirling controversy, Lacognata charged drugmakers that are licensed by the FDA have a duty to maintain supplies of a medication that is required for patient health. Specifically, she argued that Hospira violated its duty by switching manufacturing sites for Aquasol A in late 2010 without stockpiling adequate supplies to avoid what became a significant shortage.
Last summer, a federal district court judge tossed the case by determining that "there is no authority that supports (her) argument that a drug manufacturer, like Hospira, has a duty to continue supplying a patient with a drug that it knows the patient relies upon for his or her medical health" (here is the order).
However, the US Court of Appeals for the 11th Circuit has allowed an appeal to go forward. "The issue of whether drug shortage victims can recover can be decided," says her attorney Allen Black. "It's very fundamental. Is there a duty of someone who takes an FDA license to supply the drug? The doors were shut closed in district court, but were reopened by the circuit court" (here is the appeals court brief).
[UPDATE: A Hospira spokesman sent us this statement: "Hospira recognizes there are patients in need of this product and we are working diligently to return Aquasol A to market as soon as possible."]






21 Comments
If there really WAS a *Homeland Security* apparatus, there would be armed guards posted to protect the *HEALTH* of the citizens of USA from this latest industry-wide Vulture Capitalist schtick - medicine is not a *private* toy manufacturing factory in Texas, Bishop...
http://www.stanford.edu/~ayurukog/shortages.pdf
I hate this idea. But I hate, hate, hate the Soviet-style approach of the government essentially ordering companies to produce products regardless of profit motive. And obviously it's not acceptable for people to be denied essential meds. There's really no great solution.
Should be something anyone can read in plain english, even with one good eye.
Really? A precedent was set that SOME labs are NOT "medically credible"....see this conversation:
http://www.pharmalot.com/2012/11/labs-pain-drugs-urine-tests-and-body-bags/
http://www.bing.com/images/search?q=pirates+of+the+carribean+eyepatch&view=detail&id=5A453B1688D63012941C08ACDA598A567EBE8A0A
I suggest removing the PROFIT *infinity* algorithm that manages FIAT $$$$ distributed through a fractional reserve banking scheme and get back to double entry bookkeeping for Main Street and life-maintenance commerce.
Too radical...?
Profit has a limit. I can't imagine there not being enough *profit* in producing medicine that has a MINOR cost left to its production since the research and building of manufacturing plants has been paid off long ago, partially thanks to all the TAX BREAKS for doing research and building capacity to manufacture.
http://www.youtube.com/watch?v=juN1mgR3VBQ
dz-Platitudes aside, how does what you're talking about actually, you know, happen? Businesses do a cost-benefit analysis for their endeavors & do more of the ones that are profitable & do less, or stop doing altogether, the ones that aren't. That's basic economics. There's no such thing as "enough" profit just like there's no such thing as "enough" atoms.
So how do you get these guys to make more of this stuff? Incentivize them (with our tax dollars)? Force them (which is almost certainly unconstitutional)? Is there an Option 3? Like I asked, how does this actually happen?
Best example is AIDS/HIV. What is the goal? One team will tell you that it would be to "manage" the virus into *extinction*. And the other team wants to manage having a constant supply of patients for the profit value of anti-virals.
But the thing is, there will always be bacteria and viruses threatening all live species. It's never ending. So best practices - based on biologic health - should trump best practices based on profit.
If the goal is to replace many living species with mechanical contraptions and/or information storing gizmos for a much smaller human population (billions less), then the role that "health authorities" play in achieving that goal will change, and probably already has.
In this case, an agrarian-driven economy could provide this individual with everything she needs (education/tools/"living" wage) to make the specialized product on which her life depends by herself, but not as a *global* corp.
Micro-economy and macro economy might need to live side by side and those two circles may not even intersect, but rather like a watch, they turn each other.
If the goal of the macro economy is to replace living species with dead machines/gizmos, then the specialized product and the person who needs it are SOL...there is no micro economy or a macro one to support the struggle of that one unique life form.
WHY? Vitamin A deficiency is a SYSTEMIC disease. This means that there is no scientifically plausible reason for this woman to be blind in only one eye unless her ocular pathology is due to something entirely different and she is trying to cop a payday.
Take home lesson: Systemic diseases DO NOT produced unilateral pathology in paired organs. I am even more suspicious than before.